Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
4 | 4 | PSYCHIATRY//PSYCHOLOGY, CLINICAL//PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | 1867560 |
128 | 3 | AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION//HEALTH LITERACY//INFORMED CONSENT | 68930 |
2219 | 2 | GENERIC DRUGS//ORPHAN DRUGS//GENERIC SUBSTITUTION | 5103 |
7953 | 1 | GENERIC SUBSTITUTION//GENERIC DRUGS//GENERIC | 1335 |
13169 | 1 | DRUG DISCOVERY TODAY//TUFTS STUDY DRUG DEV//CLINICAL TRIAL RISK | 887 |
17771 | 1 | COMPULSORY LICENSING//ACCESS TO MEDICINES//DOHA DECLARATION | 611 |
18444 | 1 | ORPHAN DRUGS//RARE DISEASES//ORPHAN DRUG ACT | 576 |
18631 | 1 | DRUG LAG//PRIORITY REVIEW//CONDITIONAL APPROVAL | 566 |
19672 | 1 | ESSENTIAL MEDICINES//RIGHT TO HEALTH//JUDICIAL DECISIONS | 518 |
28455 | 1 | FOOD AND DRUG LAW JOURNAL//FORUM LAW MARKETS//LIFE SCI PRACTICE GRP | 225 |
29044 | 1 | PARALLEL IMPORTS//PARALLEL TRADE//GRAY MARKETS | 212 |
31066 | 1 | MCLAUGHLIN ROTMAN GLOBAL HLTH//BIOTECH AND PHARMA INDUSTRIES//ESRC INNOGEN | 173 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | GENERIC DRUGS | authKW | 467550 | 3% | 50% | 152 |
2 | ORPHAN DRUGS | authKW | 428655 | 2% | 56% | 125 |
3 | GENERIC SUBSTITUTION | authKW | 406722 | 2% | 86% | 77 |
4 | RARE DISEASES | authKW | 283197 | 4% | 24% | 189 |
5 | GENERIC MEDICINES | authKW | 249554 | 1% | 84% | 48 |
6 | GENERIC | authKW | 246318 | 3% | 27% | 149 |
7 | PARALLEL IMPORTS | authKW | 152713 | 1% | 85% | 29 |
8 | PARALLEL TRADE | authKW | 107373 | 0% | 87% | 20 |
9 | BRAND NAME DRUG | authKW | 102897 | 0% | 83% | 20 |
10 | ACCESS TO MEDICINES | authKW | 99481 | 1% | 46% | 35 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Health Policy & Services | 24767 | 12% | 1% | 600 |
2 | Health Care Sciences & Services | 17530 | 13% | 0% | 662 |
3 | Law | 11578 | 9% | 0% | 466 |
4 | Pharmacology & Pharmacy | 10131 | 27% | 0% | 1395 |
5 | Public, Environmental & Occupational Health | 4048 | 13% | 0% | 649 |
6 | Economics | 3615 | 10% | 0% | 508 |
7 | Medical Ethics | 2088 | 1% | 1% | 65 |
8 | Ethics | 1204 | 2% | 0% | 88 |
9 | Business | 1048 | 3% | 0% | 152 |
10 | International Relations | 1001 | 2% | 0% | 106 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | TUFTS STUDY DRUG DEV | 87979 | 1% | 49% | 29 |
2 | OFF ORPHAN PROD DEV | 57617 | 0% | 67% | 14 |
3 | STUDY DRUG DEV | 44589 | 0% | 43% | 17 |
4 | OFF PHARMACEUT IND | 31751 | 0% | 86% | 6 |
5 | PROGRAM REGULAT THER EUT LAW PORTAL | 30673 | 0% | 38% | 13 |
6 | LIVERPOOL HLTH ECON | 29410 | 0% | 53% | 9 |
7 | SCI TECHNOL INNOVAT NEGLECTED DIS | 27781 | 0% | 75% | 6 |
8 | POLIT MED ASSISTENCIA FARMACEUT | 24697 | 0% | 100% | 4 |
9 | WHO ABORATING PHARMACEUT PRICING REIMBU | 24693 | 0% | 67% | 6 |
10 | PUBL HLTH INTELLIGENCE STRATEG BUSINESS UNIT | 22048 | 0% | 71% | 5 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | DRUG DISCOVERY TODAY | 56437 | 3% | 6% | 153 |
2 | FOOD AND DRUG LAW JOURNAL | 41878 | 2% | 8% | 83 |
3 | THERAPEUTIC INNOVATION & REGULATORY SCIENCE | 35214 | 1% | 12% | 48 |
4 | DRUG INFORMATION JOURNAL | 31433 | 1% | 7% | 75 |
5 | ORPHANET JOURNAL OF RARE DISEASES | 28757 | 1% | 6% | 76 |
6 | EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH | 21692 | 1% | 8% | 44 |
7 | IIC-INTERNATIONAL REVIEW OF INTELLECTUAL PROPERTY AND COMPETITION LAW | 19367 | 1% | 12% | 26 |
8 | HEALTH AND HUMAN RIGHTS | 18876 | 0% | 14% | 22 |
9 | GLOBALIZATION AND HEALTH | 18748 | 1% | 8% | 39 |
10 | BIOTECHNOLOGY LAW REPORT | 16321 | 0% | 13% | 20 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GENERIC DRUGS | 467550 | 3% | 50% | 152 | Search GENERIC+DRUGS | Search GENERIC+DRUGS |
2 | ORPHAN DRUGS | 428655 | 2% | 56% | 125 | Search ORPHAN+DRUGS | Search ORPHAN+DRUGS |
3 | GENERIC SUBSTITUTION | 406722 | 2% | 86% | 77 | Search GENERIC+SUBSTITUTION | Search GENERIC+SUBSTITUTION |
4 | RARE DISEASES | 283197 | 4% | 24% | 189 | Search RARE+DISEASES | Search RARE+DISEASES |
5 | GENERIC MEDICINES | 249554 | 1% | 84% | 48 | Search GENERIC+MEDICINES | Search GENERIC+MEDICINES |
6 | GENERIC | 246318 | 3% | 27% | 149 | Search GENERIC | Search GENERIC |
7 | PARALLEL IMPORTS | 152713 | 1% | 85% | 29 | Search PARALLEL+IMPORTS | Search PARALLEL+IMPORTS |
8 | PARALLEL TRADE | 107373 | 0% | 87% | 20 | Search PARALLEL+TRADE | Search PARALLEL+TRADE |
9 | BRAND NAME DRUG | 102897 | 0% | 83% | 20 | Search BRAND+NAME+DRUG | Search BRAND+NAME+DRUG |
10 | ACCESS TO MEDICINES | 99481 | 1% | 46% | 35 | Search ACCESS+TO+MEDICINES | Search ACCESS+TO+MEDICINES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 2 |